Oncothyreon Inc.·4

Sep 28, 5:36 PM ET

Oncothyreon Inc. 4

4 · Oncothyreon Inc. · Filed Sep 28, 2015

Insider Transaction Report

Form 4
Period: 2015-09-24
KIRKMAN ROBERT L
DirectorPresident/CEO
Transactions
  • Award

    Stock Option (right to buy)

    2015-09-24+750,000750,000 total
    Exercise: $3.51Exp: 2023-09-24Common Stock (750,000 underlying)
Footnotes (1)
  • [F1]The option vests and is exercisable at the rate of 1/4th of the total shares on September 24, 2016 and then 1/48th of the total shares vest and are exercisable monthly thereafter, with 100% vested and exercisable on September 24, 2019.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION